Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients

Journal of Cataract and Refractive Surgery

Volumn 33, Issue 1, 2007, Pages 63-68

  Espiritu, Cesar Ramon G ^a   Caparas, Victor L ^a   Bolinao, Joanne G ^a  

^a American Eye Center   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; EYE DROPS; MOXIFLOXACIN; POVIDONE IODINE; PREDNISOLONE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTERIOR EYE CHAMBER; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CATARACT EXTRACTION; CELL COUNT; CELL DENSITY; CORNEA ENDOTHELIUM; CORNEA THICKNESS; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PACHOMETRY; PHACOEMULSIFICATION; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; VISION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTERIOR CHAMBER; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; AZA COMPOUNDS; CELL COUNT; ENDOPHTHALMITIS; ENDOTHELIUM, CORNEAL; EYE INFECTIONS; FEMALE; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; QUINOLINES; VISUAL ACUITY;

EID: 33845779333     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2006.09.019     Document Type: Article

References (34)

1. Masket S. Preventing, diagnosing, and treating endophthalmitis. [guest editorial]. J Cataract Refract Surg 24 (1998) 725-726
2. Gills J.P. Filters and antibiotics in irrigating solution for cataract surgery. [letter]. J Cataract Refract Surg 17 (1991) 385
3. Gimbel H.V., Sun R., and de Brof B.M. Prophylactic intracameral antibiotics during cataract surgery: the incidence of endophthalmitis and corneal endothelial cell loss. Eur J Implant Refract Surg 6 (1994) 280-285
4. Gimbel H.V., and Sun R. Prophylactic intracameral vancomycin and CME. [letter]. Ophthalmology 107 (2000) 1614-1615
5. Axer-Siegel R., Stiebel-Kalish H., Rosenblatt I., et al. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology 106 (1999) 1660-1664
6. Seppälä H., Al-Juhaish M., Järvinen H., et al. Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients. J Cataract Refract Surg 30 (2004) 307-315
7. Centers for Disease Control. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep 51 (2002) 565-567
8. Barry P., Seal D.V., Gettinby G., et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg 32 (2006) 407-410
9. Seal D.V., Barry P., Gettinby G., et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: case for a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg 32 (2006) 396-406
10. Mamalis N., Edelhauser H.F., Dawson D.G., et al. Toxic anterior segment syndrome. J Cataract Refract Surg 32 (2006) 324-333
11. Mather R., Karenchak L.M., Romanowski E.G., and Kowalski R.P. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133 (2002) 463-466
12. Kowalski R.P., Romanowski E.G., Mah F.S., et al. Intracameral Vigamox® (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol 140 (2005) 497-504
13. Stroman D.W., Dajcs J.J., Cupp G.A., and Schlech B.A. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%; a new topical fluoroquinolone. Surv Ophthalmol 50 suppl (2005) S16-S31
14. Trinkhaus-Randall V., Edelhauser H.F., Leibowitz H.M., and Freddo T.F. Corneal structure and function. In: Leibowitz H.M., and WaringIII G.O. (Eds). Corneal Disorders; Clinical Diagnosis and Management. 2nd ed. (1998), WB Saunders, Philadelphia, PA 21-27
15. Gonnering R., Edelhauser H.F., Van Horn D.L., and Durant W. The pH tolerance of rabbit and human corneal endothelium. Invest Ophthalmol Vis Sci 18 (1979) 373-390
16. Edelhauser H.F., Hanneken A.M., Pederson H.J., and Van Horn D.L. Osmotic tolerance of rabbit and human corneal endothelium. Arch Ophthalmol 99 (1981) 1281-1287
17. Nussenblatt R.B., Whitcup S.M., and Palestine A.G. Uveitis: Fundamentals and Clinical Practice. 2nd ed. (1996), Mosby-Year Book, St Louis, MO 61-62
18. West E.S., Behrens A., McDonnell P.J., et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population between 1994 and 2001. Ophthalmology 112 (2005) 1388-1394
19. Ciulla T.A., Starr M.B., and Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology 109 (2002) 13-24 questions for CME credit request, 25-26
20. Isenberg S.J., Apt L., Yoshimori R., et al. Efficacy of topical povidone-iodine during the first week after ophthalmic surgery. Am J Ophthalmol 124 (1997) 31-35
21. Alfonso E., and Crider J. Ophthalmic infections and their anti-infective challenges. Surv Ophthalmol 50 suppl (2005) S1-S6
22. Schlech B.A., and Alfonso E. Overview of the potency of moxifloxacin ophthalmic solution 0.5% (Vigamox®). Surv Ophthalmol 50 Suppl (2005) S7-S15
23. O'Brien P.D., Fitzpatrick P., Kilmartin D.J., and Beatty S. Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident. J Cataract Refract Surg 30 (2004) 839-843
24. Montan P.G., Wejde G., Setterquist H., et al. Prophylactic intracameral cefuroxime: evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 28 (2002) 982-987
25. Peyman G.A., Sathar M.L., and May D.R. Intraocular gentamicin as intraoperative prophylaxis in South India eye camps. Br J Ophthalmol 61 (1977) 260-262
26. Kramann C., Pitz S., Schwenn O., et al. Effects of intraocular cefotaxime on the human corneal endothelium. J Cataract Refract Surg 27 (2001) 250-255
27. Cheng H., Bates A.K., Wood L., and McPherson K. Positive correlation of corneal thickness and endothelial cell loss; serial measurements after cataract surgery. Arch Ophthalmol 106 (1988) 920-922
28. Amon M., Menapace R., Radax U., and Papapanos P. Endothelial cell density and corneal pachymetry after no-stitch, small-incision cataract surgery. Doc Ophthalmol 81 (1992) 301-307
29. Mindel J.S. Pharmacokinetics. In: Tasman W., and Jaeger E.A. (Eds). Duane's Foundations of Clinical Ophthalmology on CD-ROM (2006), Lippincott Williams & Wilkins, Philadelphia, PA vol. 3, chap 23
30. Schentag J.J. Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae. J Chemother 14 suppl 2 (2002) 13-21
31. Metzler K., Hansen G.M., Hedlin P., et al. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. Int J Antimicrob Agents 24 (2004) 161-167
32. Ferro J.F., de-Pablos M., Logroño M.J., et al. Postoperative contamination after using vancomycin and gentamicin during phacoemulsification. Arch Ophthalmol 115 (1997) 165-170
33. Lehmann O.J., Thompson J.P., White L.O., et al. Half-life of intracameral gentamicin after phacoemulsification. J Cataract Refract Surg 23 (1997) 883-888
34. Mendívil Soto A., and Mendívil M.P. The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery. Am J Ophthalmol 131 (2001) 293-300